Literature DB >> 18261820

RNase H activity: structure, specificity, and function in reverse transcription.

Sharon J Schultz1, James J Champoux.   

Abstract

This review compares the well-studied RNase H activities of human immunodeficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (MoMLV) reverse transcriptases. The RNase H domains of HIV-1 and MoMLV are structurally very similar, with functions assigned to conserved subregions like the RNase H primer grip and the connection subdomain, as well as to distinct features like the C-helix and loop in MoMLV RNase H. Like cellular RNases H, catalysis by the retroviral enzymes appears to involve a two-metal ion mechanism. Unlike cellular RNases H, the retroviral RNases H display three different modes of cleavage: internal, DNA 3' end-directed, and RNA 5' end-directed. All three modes of cleavage appear to have roles in reverse transcription. Nucleotide sequence is an important determinant of cleavage specificity with both enzymes exhibiting a preference for specific nucleotides at discrete positions flanking an internal cleavage site as well as during tRNA primer removal and plus-strand primer generation. RNA 5' end-directed and DNA 3' end-directed cleavages show similar sequence preferences at the positions closest to a cleavage site. A model for how RNase H selects cleavage sites is presented that incorporates both sequence preferences and the concept of a defined window for allowable cleavage from a recessed end. Finally, the RNase H activity of HIV-1 is considered as a target for anti-virals as well as a participant in drug resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261820      PMCID: PMC2464458          DOI: 10.1016/j.virusres.2007.12.007

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  157 in total

1.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  RNA-primed initiation of Moloney murine leukemia virus plus strands by reverse transcriptase in vitro.

Authors:  W I Finston; J J Champoux
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

3.  Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice.

Authors:  Susana M Cerritelli; Ella G Frolova; Chiguang Feng; Alexander Grinberg; Paul E Love; Robert J Crouch
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

4.  Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Crystal structure of an RNA.DNA hybrid reveals intermolecular intercalation: dimer formation by base-pair swapping.

Authors:  Gye Won Han; Mary L Kopka; David Langs; Michael R Sawaya; Richard E Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

7.  An unusual sugar conformation in the structure of an RNA/DNA decamer of the polypurine tract may affect recognition by RNase H.

Authors:  Mary L Kopka; Laurence Lavelle; Gye Won Han; Ho-Leung Ng; Richard E Dickerson
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

8.  A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity.

Authors:  Michael A Parniak; Kyung-Lyum Min; Scott R Budihas; Stuart F J Le Grice; John A Beutler
Journal:  Anal Biochem       Date:  2003-11-01       Impact factor: 3.365

9.  Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors.

Authors:  Klaus Klumpp; Julie Qi Hang; Surendran Rajendran; Yanli Yang; Andre Derosier; Philippe Wong Kai In; Hilary Overton; Kevin E B Parkes; Nick Cammack; Joseph A Martin
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

10.  Role of the Reverse Transcriptase, Nucleocapsid Protein, and Template Structure in the Two-step Transfer Mechanism in Retroviral Recombination.

Authors:  Ricardo H Roda; Mini Balakrishnan; Mark N Hanson; Birgitta M Wohrl; Stuart F J Le Grice; Bernard P Roques; Robert J Gorelick; Robert A Bambara
Journal:  J Biol Chem       Date:  2003-06-11       Impact factor: 5.157

View more
  59 in total

1.  Understanding the effect of magnesium ion concentration on the catalytic activity of ribonuclease H through computation: does a third metal binding site modulate endonuclease catalysis?

Authors:  Ming-Hsun Ho; Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

Review 2.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity.

Authors:  Katherine J Fenstermacher; Jeffrey J DeStefano
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

Review 4.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

5.  Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Mol Interv       Date:  2009-04

Review 6.  Retroviral integrase superfamily: the structural perspective.

Authors:  Marcin Nowotny
Journal:  EMBO Rep       Date:  2009-01-23       Impact factor: 8.807

7.  Efavirenz stimulates HIV-1 reverse transcriptase RNase H activity by a mechanism involving increased substrate binding and secondary cleavage activity.

Authors:  John M Muchiri; Dongge Li; Carrie Dykes; Robert A Bambara
Journal:  Biochemistry       Date:  2013-07-09       Impact factor: 3.162

Review 8.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

9.  Preferred sequences within a defined cleavage window specify DNA 3' end-directed cleavages by retroviral RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

10.  Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.

Authors:  Martin T Christen; Lakshmi Menon; Nataliya S Myshakina; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2012-08-31       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.